Colorectal adenocarcinoma is a type of cancer that starts in the large intestine. Colorectal stands for your colon and rectum, which make up the large intestine. There are different types of colon and rectal cancer, but adenocarcinoma is the most common.
Mou et al. speculated that ATOH1 may influence the efficacy of Immune checkpoint inhibitors therapy in patients with colorectal adenocarcinoma by affecting the immune microenvironment and immunogenicity of the tumor 1).